Therapy Areas
20 January 2021 - - US-based biotechnology company Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) has closed its underwritten public offering of 7,868,421 shares of its common stock at a public offering price of USD 9.50 per share, including 1,026,315 add...
20 January 2021 - - US-based adult stem cell therapies developer BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) is highlighting the peer-reviewed publication of a preclinical study in the journal Stem Cell and Research Therapy, the c...
20 January 2021 - - The US Food and Drug Administration has accepted its supplemental Biologics License Application for Opdivo (nivolumab), in combination with fluoropyrimidine- and platinum-containing chemotherapy, for the treatment of pat...
20 January 2021 - - The first patient has been dosed in a Phase 1 clinical trial evaluating FT-7051, a selective inhibitor of CBP/p300, a known co-activator of the androgen receptor in men with metastatic castration-resistant prostate cancer (mCRPC),...
20 January 2021 - - US-based Aveo Oncology (NASDAQ: AVEO) has received a commitment letter for an incremental USD 10m loan from Hercules Capital, Inc. (NYSE: HTGC) and its affiliates, to be added to the current tranched, USD 35m debt facility secured...
20 January 2021 - The official twitter account, promoting the Sputnik V COVID-19 vaccine, tweeted on 20 January 2021 that Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, has filed for registration of the COVID-19 Sputnik V...
20 January 2021 - Lightpoint Medical reported on Tuesday the receipt of the CE Mark approval for the launch of the world's first robotic gamma probe SENSEI across hospitals in Europe for intra-operative detection of sentinel lymph nodes as well ...